Skip to main content

Biolife Solutions

BioLife Solutions Inc is an American cell and gene therapy bioproduction tools company delivering biopreservation media and cell processing solutions. The company manufactures proprietary cell preservation media including HypoThermosol and CryoStor, alongside automated thaw systems and controlled-rate freezers. Main revenue drivers derive from commercial sales of biopreservation media consumables, cell processing equipment, and cold-chain logistics services to cell therapy developers. BioLife Solutions serves cell and gene therapy developers, biopharmaceutical companies, cord blood banks, and regenerative medicine centers globally. The company holds a market-leading global position in biopreservation media for cell-based therapies and regenerative medicine. Headquartered in Bothell, Washington, BioLife Solutions Inc is listed on the Nasdaq Stock Market.

2 of the funds FundTelligence covers report a position in Biolife Solutions.

Legal name
BIOLIFE SOLUTIONS
Sector
Health Care
Country
United States
Funds holding it
2

Funds holding Biolife Solutions

Loading...